{{Rsnum
|rsid=2292593
|Gene=RGS9
|Chromosome=17
|position=65201802
|Orientation=minus
|GMAF=0.2603
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RGS9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 85.0 | 15.0 | 0.0
| HCB | 43.1 | 43.1 | 13.9
| JPT | 54.9 | 35.4 | 9.7
| YRI | 25.9 | 49.7 | 24.5
| ASW | 42.1 | 43.9 | 14.0
| CHB | 43.1 | 43.1 | 13.9
| CHD | 40.4 | 52.3 | 7.3
| GIH | 78.2 | 19.8 | 2.0
| LWK | 28.2 | 51.8 | 20.0
| MEX | 43.1 | 37.9 | 19.0
| MKK | 46.8 | 41.7 | 11.5
| TSI | 88.2 | 11.8 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=18548510
|Title=Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}